Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

AMP-303 safely increases hair growth in men with hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Injecting monocyto-angiotropin into hare skin increases hair growth by forming new blood vessels.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Inflammation damages sweat ducts, causing sweat gland injury.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Dutasteride is effective for treating hair loss.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Certain alkaloids could help create new coronavirus drugs.

Higher alarin levels might link hair loss and metabolic syndrome.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Testosterone affects blood vessel relaxation in hypertensive rats.

The inhibitor affects androgen metabolism but not ovarian function.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

PAD enzymes play a key role in hair growth and structure.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Avicennia marina extract can significantly promote hair growth in androgenic alopecia patients.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.